Citi's Collins on Investing in Covax

The transcript discusses the role of COVAX and GAVI in global vaccine distribution, highlighting challenges such as supply chain issues and funding. It explores innovative solutions and the use of capital markets to address these challenges. The discussion also covers lessons learned and future applications, including potential uses for climate change. The impact of COVID-19 variants on business operations and client interactions is also addressed.

What role does City play in the COVAX facility?

How has GAVI transitioned in its role regarding vaccine distribution?

What challenges are faced in vaccine distribution to developing countries?

What is the significance of the $9.7 billion donation mentioned in the text?

What innovative strategies are being employed to fund vaccine distribution?

What lessons can be learned from the current pandemic response for future global health crises?

How does the text describe the relationship between public and private sectors in vaccine distribution?